Beijing Chunlizhengda Medical Instruments Co., Ltd. Stock

Equities

1858

CNE100001TP1

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:35 2024-04-19 am EDT 5-day change 1st Jan Change
10.4 HKD -1.89% Intraday chart for Beijing Chunlizhengda Medical Instruments Co., Ltd. +4.21% -16.53%

Financials

Sales 2024 * 1.5B 207M 1.62B Sales 2025 * 1.9B 263M 2.06B Capitalization 6.82B 942M 7.38B
Net income 2024 * 335M 46.27M 362M Net income 2025 * 428M 59.11M 463M EV / Sales 2024 * 4.55 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 3.58 x
P/E ratio 2024 *
10.9 x
P/E ratio 2025 *
8.59 x
Employees 1,231
Yield 2024 *
-
Yield 2025 *
-
Free-Float 37.96%
More Fundamentals * Assessed data
Dynamic Chart
Beijing Chunlizhengda Medical Instruments Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 31 July 2024 CI
Beijing Chunlizhengda Medical Instruments Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Chunlizhengda Medical Instruments to Invest 580 Million Yuan in Bank of Beijing’s Structured Deposit Products MT
Beijing Chunlizhengda Medical Instruments to Invest 215 Million Yuan in Bank of Beijing’s Structured Deposit Products MT
Chunlizhengda Medical Instruments' Q3 Attributable Profit Falls 3.5% MT
Beijing Chunlizhengda Medical Instruments Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Chunlizhengda Medical Instruments' H1 Profit Declines MT
Beijing Chunlizhengda Medical Instruments Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Beijing Chunlizhengda Medical Instruments Co., Ltd. Announces Changes in Composition of Board Committees CI
Beijing Chunlizhengda Medical Instruments Co., Ltd. Announces Retirement of Ge Changyin as an Independent Non-Executive Director CI
Beijing Chunlizhengda Medical Instruments Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2022 CI
Chunlizhengda Medical Avails of 215 Million Yuan Structured Deposit Program frm Bank of Beijing MT
Chunlizhengda Medical Instruments Subscribes to 605 Million Yuan of Structured Deposit Products MT
Chunlizhengda Medical’s January to March Profit Falls 24.53% MT
Beijing Chunlizhengda Medical Instruments Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
More news
1 day-1.89%
1 week+4.21%
Current month+10.64%
1 month+7.22%
3 months+4.31%
6 months-18.88%
Current year-16.53%
More quotes
1 week
9.79
Extreme 9.79
10.86
1 month
9.06
Extreme 9.06
10.86
Current year
8.32
Extreme 8.32
12.56
1 year
8.32
Extreme 8.32
21.05
3 years
7.63
Extreme 7.63
34.95
5 years
6.00
Extreme 6
63.00
10 years
1.60
Extreme 1.6
63.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 39 13-12-31
Founder 52 10-09-16
Founder 54 98-01-31
Members of the board TitleAgeSince
Director/Board Member 62 20-08-24
Founder 54 98-01-31
Founder 52 10-09-16
More insiders
Date Price Change Volume
24-04-19 10.4 -1.89% 524 966
24-04-18 10.6 +3.92% 790,850
24-04-17 10.2 +4.19% 232,000
24-04-16 9.79 -1.61% 229,000
24-04-15 9.95 -0.30% 134,505

Delayed Quote Hong Kong S.E., April 19, 2024 at 04:08 am EDT

More quotes
Beijing Chunlizhengda Medical Instruments Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of implantable orthopedic medical devices. The Company's main products are joint prosthesis products and spine implant products. The joint prosthesis products cover four human joints: hip, knee, shoulder and elbow. The spine implant products are a full range of product combinations of spinal internal fixation systems. The Company's products are exported to Asia, South America, Africa, Oceania, Europe and other countries and regions.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
9.798 CNY
Average target price
18.35 CNY
Spread / Average Target
+87.31%
Consensus

Annual profits - Rate of surprise